Universität Wien
Warning! The directory is not yet complete and will be amended until the beginning of the term.

270035 VO Medical Radiochemistry II (2022S)

Tracer Development - from Bench to Bed

3.00 ECTS (2.00 SWS), SPL 27 - Chemie
Moodle

Registration/Deregistration

Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
Register/Deregister for this course

Details

Language: German

Examination dates

Lecturers

Classes (iCal) - next class is marked with N

11 x 90 min Units, web-based (Moodle/Jitsi or Webex), every Tuesday at 4:30 till 6 pm
Starting from 1st March 2022, last unit will be hold on 24. May 2022

  • Tuesday 01.03. 16:30 - 18:00 Digital
  • Tuesday 08.03. 16:30 - 18:00 Digital
  • Tuesday 15.03. 16:30 - 18:00 Digital
  • Tuesday 22.03. 16:30 - 18:00 Digital
  • Tuesday 29.03. 16:30 - 18:00 Digital
  • Tuesday 05.04. 16:30 - 18:00 Digital
  • Tuesday 26.04. 16:30 - 18:00 Digital
  • Tuesday 03.05. 16:30 - 18:00 Digital
  • Tuesday 10.05. 16:30 - 18:00 Digital
  • Tuesday 17.05. 16:30 - 18:00 Digital
  • Tuesday 24.05. 16:30 - 18:00 Digital

Information

Aims, contents and method of the course

-Basics in radiopharmaceutical sciences, preclinical evaluation and nuclear medicine
-Pharmacokinetics and Modelling
-Special Challenges in neuro-radiopharmaceutical development (blood brain barrier)
- Methods of radiopharmaceutical drug development and process
-Radiopharmaceuticals for diagnostic, therapeutic use and developments in neuroimaging
-Preclinical studies (in vitro, animal studies) and clinical studies

Assessment and permitted materials

Multiple Choice Test (written/online), teaching material permitted

3 Dates (14.06.22 & 28.06.22 & 27.09)

Minimum requirements and assessment criteria

>50% correct answers to pass exam
-To learn about the most important pharmacological criteria in radiopharmaceutical drug development
-To know the most important radiopharmaceuticals for nuclear medicine
-To hear about important methods in drug development
-To understand essentials in (radio)pharmacological behavior
-To understand the theranostic concept
-To understand preclinical and clinical study designs (development process)

Examination topics

See above, minimum requirements and assessment criteria

Reading list

1. "Handbook of Radiopharmaceuticals" von Michael Welch und Carol S. Redvanly
2. "Radiopharmaceuticals: in Nuclear Pharmacy and Nuclear Medicine" von Richard J., Ph.D. Kowalsky, Steven W., Ph.D. Falen
3. . ETH ZÜRICH - RADIOPHARMAZEUTISCHE CHEMIE http://www.pharma.ethz.ch/institute_groups/radiopharmaceutical_science/lectures/index
4. Universität Würzburg - KURSUS DER NUKLEARMEDIZIN http://www.uni-wuerzbrug.de/nuklearmedizin/kursus/Kursus.htm
5. 5. The role of radiopharmaceuticals in drug discovery and development. Kairemo K. Curr Pharm Des. 2009;15(9):926-7
6. Molecular Imaging with PET. Ametamey S, Honer M, Schubiger PA, Chem. Rev. 2008, 108, 1501–1516
7. Animal Models for Human Cancer, Edited by Marianne I. Martic-Kehl and P. August Schubiger, Dicovery and Development of Novel Therapeutics, Volume 69

Association in the course directory

AC-4

Last modified: Th 11.05.2023 11:28